Small molecule agents for triple negative breast cancer: Current status and future prospects

Small molecule agents for triple negative breast cancer: Current status and future prospects

Triple-negative breast cancer (TNBC) is a subtype of breast cancer with poor prognosis. The number of cases increased by 2.26 million in 2020, making it the most commonly diagnosed cancer type in the world. TNBCs lack hormone receptor (HR) and human epidermal growth factor 2 (HER2), which limits tre...

Full description

Bibliographic Details
Main Authors: Yan Ou, Mengchao Wang, Qian Xu, Binxu Sun, Yingjie Jia
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Translational Oncology
Subjects:
Triple-negative breast cancer
Small molecule drugs
Targeted therapies
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523324000196

Internet

http://www.sciencedirect.com/science/article/pii/S1936523324000196

Similar Items